Loading…
Egyptian drugmakers are reportedly seeking price increases of up to 20% to offset the weaker pound and higher raw-material costs. The Egyptian Drug Authority says it has received no exceptional requests for such increases and says any price changes must follow the new formula and be supported by cost documentation.
The story concerns medicine pricing rather than feed or agricultural commodities, so it provides no direct supply, demand or price signal for the listed markets.
enterpriseam.comNov 9, 2026Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
